A detailed history of Advantage Trust CO transactions in Merck & Co., Inc. stock. As of the latest transaction made, Advantage Trust CO holds 350 shares of MRK stock, worth $35,812. This represents 0.03% of its overall portfolio holdings.

Number of Shares
350
Previous 350 -0.0%
Holding current value
$35,812
Previous $46.2 Million 6.18%
% of portfolio
0.03%
Previous 0.03%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

SELL
$113.24 - $131.95 $39,634 - $46,182
-350 Reduced 50.0%
350 $46.2 Million
Q4 2023

Feb 07, 2024

BUY
$100.18 - $109.02 $70,126 - $76,314
700 New
700 $76.3 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $259B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Advantage Trust CO Portfolio

Follow Advantage Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advantage Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Advantage Trust CO with notifications on news.